Current Posters and Presentations
Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations include:
Academy of Clinical Laboratory Physicians and Scientists (ACLPS)
Atlanta, GA, Jun 6-8, 2013
Wyness S, Grenache DG - Presentation
Desai D, Wyness S, Greene DN, Olson K, Wiley C, Grenache D. Can the hCG Discriminatory Zone be Utilized Without Regard to a Specific hCG Assay?
Suh-Lailam BB, Mao R, Procter M, Grenache DG ─ Presentation
Suh-Lailam BB, Runels S, Mao R, Procter M, Hopf H, Grenache DG. Predicting succinylcholine recovery time: a study of Butyrylcholinesterase genotype and phenotype in normal individual.
Strathmann FG, Straseski JA- Poster
Hackenmueller SA, Barakauskas VE, Strathmann FG, Straseski JA. Re-visiting the dynamic relationship between erythropoietin and hematocrit.
American Society for Mass Spectrometry (ASMS)
Minneapolis, MN, Jun 9-13, 2013
Johnson-Davis KL─ Poster
Blachon G, Johnson-Davis KL, Lacoursiere J, Picard P, Auger S, Dion-Fortier A. Cross validation between LDTD-MS/MS and LC-MS/MS for the determination of 4 immunosuppressant drugs in whole blood.
Hereditary Hemorrhagic Telangiectasia (HHT)
Cork, Ireland, Jun 12-15, 2013
Wooderchak-Donahue W, O’Fallon B, Bayrak-Toydemir P – Presentation
Wooderchak-Donahue W, McDonald J, O’Fallon B, Upton PD, Li W, Roman BL, Young S, Plant P, Tamas G, Langa C, Morrell NW, Botella LM, Bernabeu C, Stevenson DA, Runo JR, Bayrak-Toydemir P. Mutations on a new gene cause a new vascular malformation disorder similar to hereditary hemorrhagic telangiectasia.
Wooderchak-Donahue W, O’Fallon B, Lewis T, Bayrak-Toydemir P- Poster
Wooderchak-Donahue W, O’Fallon B, Lewis T, McDonald J, Plant P, Stevenson DA, Grimmer JF, Bayrak-Toydemir P. Clinical utility of a next generation sequencing panel in the diagnosis of hereditary hemorrhagic telangiectasia (HHT) and other syndromes featuring vascular malformations.
The Endocrine Society (ENDO)
San Francisco, CA Jun 15-18, 2013
Kushnir MM, Rockwood AL, Meikle AW – Poster
Kushnir MM, Rockwood AL, Hoofnagle AN, Meikle AW. Mass spectrometry based method for accurate measurement of thyroglobulin in the presence of anti-thyroglobulin autoantibodies.
European Cytogenetics Conference
Dublin, Ireland, Jun 29 – July 2, 2013
Rowe LR, Paxton CN, South ST – Poster
Rowe LR, Paxton CN, Thacker HM, Opitz JM, Schiffman JD, Haddadin ZM, Erickson LK, South ST. Comparison of two array comparative genomic hybridization platforms for analysis of formalin-fixed, paraffin-embedded stillbirth tissue
International Symposium on Myelodysplastic Syndromes
Berlin, Germany, May 8–11, 2013
Dames S, Mao R, Salama ME—Presentation
Dames S, Mao R, Duncavage EJ, Shami PJ, Salama ME. Detection of mtDNA variants between CD33+ and CD34+ cell-sorted populations in patients with MDS.
Hsu P, Zantek ND, Meijer P, Brody J, Zhang X, Smock KJ, Van Cott EM. FXIII assays: a problem for laboratory diagnosis? An analysis of international proficiency testing results.
International Society for Laboratory Hematology (ISLH)
Toronto, Canada, May 10–12, 2013
Smock KJ, Ledford-Kraemer MR, Meijer P, Hsu P, Van Cott EM. Update on proficiency test results for heparin-induced thrombocytopenia: a report from the North American Specialized Coagulation Laboratory Association.
Crist RA, Heikal NM, Rodgers GM, Smock KJ—Poster
Crist RA, Heikal NM, Rodgers GM, Smock KJ. Ultracentrifugation appears to be a viable method to eliminate interference from gross lipemia for some specialized coagulation assays.
Association of Clinical Scientists (ACS)
Boston, MA, May 15–]19, 2013
Gehrie E, Keiser A, Dawling S, Travis J, Strathmann FG, Booth GS. A novel method for the assessment of lead exposure in pediatric transfusions.
Johnson-Davis KL, Picard P. Advancements in analytical methods for immunosuppressive drug testing.
Ardon O, Pasquali M, Hill HR, Slev P—Poster
Ardon O, Warren J, Xiong W, Randall H, Pasquali M, Kusukawa N, Chen K, Hill HR, Slev P. Newborn screening for severe combined immunodeficiency (SCID): a pilot study.
American Society for Microbiology (ASM)
Denver, CO, May 18–21, 2013
Slechta ES, Barker AP, Hanson K—Poster
Slechta ES, Hamula CS, Barker AP, Hanson K. Differentiation of Mycobacterium abscessus group isolates by sequence analysis of the Inducible Macrolide Resistance Gene erm.
Couturier B, Couturier M, Kalp K, Fisher MA—Poster
Couturier B, Couturier M, Kalp K, Fisher MA. Detection of non-jejuni/coli Campylobacter species from stool with an immunochromatographic antigen detection assay.
Keystone Symposia on Molecular and Cellular Biology
Whistler, British Columbia, Canada, April 4–9, 2013
Escobar H, Rockwood AL, Jensen PE, Delgado JC—Poster
Zhou Z, Reyes-Vargas E, Escobar H, Rudd B, Rockwood AL, Jensen PE, Delgado JC. Type-1 diabetes associated HLA-DQ molecules are relatively resistant to HLA-DM catalytic function.
American Association for Clinical Chemistry (AACC) Rocky Mountain Local Section
Salt Lake City, UT April 15–16, 2013
Smock KJ. New anticoagulants: coagulation laboratory implications.
American Society for Investigative Pathology (ASIP)
Boston, MA, April 20–24, 2013
Rodgers GM, Jama MA, Smock KJ—Poster
Desai DS, Lyon E, Rodgers GM, Jama MA, Wallentine SL, Smock KJ. Gene sequencing aids in differentiation of von Willebrand disease type 2B from platelet-type vWD.
Clinical Immunology Society (CIS)
Miami, FL, April 25–28, 2013
Ravkov EV, Pavlov IY, Martins TB, Hill HR, Delgado JC—Poster
Ravkov EV, Pavlov IY, Martins TB, Hill HR, Delgado JC. Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes.
Pan American Society for Clinical Virology (PASCV)
Daytona, FL, April 27–May 1, 2013
Ardon O, Slev P—Poster
Ardon O, Blackley J, Griffiths S, Slev P. Comparison of the AVIOQ HTLV I/II Microelisa System to MP Diagnostics (MPD) HTLV I/II Elisa 4.0 assay for detection of HTLV I/II.
Ardon O, Slev P—Poster
Ardon O, Blackley J, Griffiths S, Slev P. Evaluation of multispot for detection of HIV-1 and HIV-2 infection.
Hymas W, Hillyard D—Poster
Hymas W, Hillyard D. Evaluation of the Genmark eSensor respiratory virus panel.
Hymas W, Hillyard D—Poster
Hymas W, Hillyard D. Development and validation of a multiplex real-time RT-PCR assay for influenza A (H3N2 and 2009-H1N1) typing.
Wittwer CT—Presentation/ Workshop
Wittwer CT. Extreme PCR: Efficient amplification in less than one minute.
United States and Canadian Academy of Pathology (USCAP)
Baltimore, MD, Mar 2–8, 2013
Wilson A, Samowitz W, Geiersbach K—Poster
Affolter K, Wilson A, Samowitz W, Geiersbach K. Base pair changes in assessing microsatellite instability and correlation to mismatch repair status by
Samowitz W, Bronner M—Poster
Affolter K, Samowitz W, Bronner M. BRAF V600E immunohistochemical stain in colorectal carcinomas.
Liew M, Kelley TW, Bahler DW—Poster
Hart EH, Liew M, Hill S, Mohl RA, Kelley TW, Bahler DW. Clinical laboratory validation of an improved flow cytometry assay for detection of ZAP-70.
Welker NC, Bronner MP—Poster
Lin J, Welker NC, Bronner MP. Common microRNA biomarkers to characterize inflammatory bowel disease.
Perkins SL, Wilson A, South S, Toydemir RM, Bahler DW, Salama ME—Poster
Du S, Perkins SL, Wilson A, South S, Toydemir RM, Bahler DW, Salama ME. Expression patterns of aberrant antigens on neoplastic PlasmaCells and their association with CKS1B positive cytogenetic subgroup.
Wallander ML, Tripp SR, Cohen MB—Poster
Matynia AP, Wallander ML, Tripp SR, Akerley WL, Cohen MB. Expression of PD-1 in non-small cell carcinoma of the lung.
Jedrzkiewicz J, Fisher M. Identification of Burkholderia cepacia complex isolates by MALDI-TOF MS from Burkholderia cepacia selective agar.
Welker NC Bronner MP—Presentation
Welker NC, Lin J, Bronner MP. miRNA profiling by next-generation sequencing and miRNA ISH in ulcerative colitis neoplastic progression.
Albertson DJ, Bearss JJ, Bearss DJ, Tripp S, Liu T. Proviral integration site Moloney Murine leukemia virus (PIM) expression in urothelial carcinoma.
Duncavage E, Schumacher JA, Szankasi P, Kelley TW—Poster
Duncavage E, Schumacher JA, Szankasi P, Kelley TW. T-cell clonality testing by next-generation sequencing: a comparison of benchtop sequencing platforms.
Gomez-Gelvez JC, Salama M, Cogan C, Leavitt M, Inamdar K. Prognostic impact of tumor microenvironment on diffuse large B-cell lymphoma treated with R-CHOP.
American Academy of Neurology (AAN)
San Diego, CA, Mar 16–23, 2013
Smock KJ, Rodgers GM, Crist RA—Poster
Weathered NR, Smock KJ, Call KD, Wold JJ, Rodgers GM, Crist RA, Skalabrin EJ, Wang H, Majersik JJ. Prolongation of INR after tPA in patients presenting as a stroke code.
Mass Spectrometry: Applications to the Clinical Lab (MSACL)
San Diego, CA, Feb 9–13, 2013
Clark ZD, Strathmann FG, McMillin GA—Presentation
Clark ZD, Strathmann FG, McMillin GA. Diluting and shooting yourself in the foot: complications with sample-to-sample variations in signal suppression.
Rule G, Rockwood AL, Johnson-Davis KL—Poster
Rule G, Rockwood AL, Johnson-Davis KL. A method for determination of Leflunomide Metabolite over a 40,000-fold dynamic range.
Juenke JM, McMillian GA, Johnson-Davis KL—Poster
Juenke JM, McMillian GA, Johnson-Davis KL. Application of ultra high performance liquid chromatography tandem mass spectrometry to the analysis of tamoxifen and metabolites in serum and plasma, to support a genotyping study.
Haglock C. Development and validation of a matrix-matched assay to measure iodine in urine and serum by inductively coupled plasma-mass spectrometry.
Strathmann FG. Screen, reflex, confirm, repeat: is that the best we can do for pain management testing?
Ray JA, La'ulu S, Rockwood AL, Meikle AW—Poster
Ray JA, La'ulu S, Chittamma A, Woroniecki W, Sadjadi S, Huynh E, Rockwood AL, Meikle AW. Selectivity enhancement in the analysis of three endogenous steroids using differential ion mobility coupled with LC-MS/MS.
American Federation for Medical Research (AMFR) Western Regional Meeting
Carmel, CA, January 24–26, 2013
Martins TB, Jaskowski TD, Augustine NH, Kumanovics A, Tebo AE, Hill HR—Poster
Martins TB, Jaskowski TD, Brickell LJ, Augustine NH, Kumanovics A, Tebo AE, Hill HR. Higher incidence of IGG Anti-IGA antibodies in IGA deficient females with suspected celiac disease.